日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adipose gene expression profiles related to metabolic syndrome using microarray analyses in two different models

利用微阵列分析在两种不同模型中研究与代谢综合征相关的脂肪组织基因表达谱

Yoo, Hye Jin; Hwang, Hwan-Jin; Jung, Tae Woo; Ryu, Ja Young; Hong, Ho Cheol; Choi, Hae Yoon; Baik, Sei Hyun; Choi, Kyung Mook

Changes in the clinical manifestations of primary aldosteronism

原发性醛固酮增多症临床表现的变化

Kim, Sun Hwa; Ahn, Jae Hee; Hong, Ho Cheol; Choi, Hae Yoon; Kim, Yoon Jung; Kim, Nam Hoon; Yoo, Hye Jin; Kim, Hee Young; Seo, Ji A; Kim, Nan Hee; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop

Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease

内脏肥胖和非酒精性脂肪肝患者体内硒蛋白P水平升高

Choi, Hae Yoon; Hwang, Soon Young; Lee, Chang Hee; Hong, Ho Cheol; Yang, Sae Jeong; Yoo, Hye Jin; Seo, Ji A; Kim, Sin Gon; Kim, Nan Hee; Baik, Sei Hyun; Choi, Dong Seop; Choi, Kyung Mook

Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome.

前粒蛋白和 C1q/TNF 相关蛋白-3 (CTRP3) 对患有或未患有代谢综合征的受试者的炎症和动脉粥样硬化的影响

Yoo Hye Jin, Hwang Soon Young, Hong Ho Cheol, Choi Hae Yoon, Yang Sae Jeong, Choi Dong Seop, Baik Sei Hyun, Blüher Matthias, Youn Byung-Soo, Choi Kyung Mook

Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats

选择性醛固酮阻滞剂依普利酮对2型糖尿病大鼠糖尿病肾病发展的影响

Ahn, Jae Hee; Hong, Ho Cheol; Cho, Myong Jin; Kim, Yoon Jung; Choi, Hae Yoon; Eun, Chai Ryoung; Yang, Sae Jeong; Yoo, Hye Jin; Kim, Hee Young; Seo, Ji A; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Kim, Nan Hee

Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes

2型糖尿病患者循环中网膜素-1水平与动脉僵硬和颈动脉斑块的相关性

Yoo, Hye Jin; Hwang, Soon Young; Hong, Ho Cheol; Choi, Hae Yoon; Yang, Sae Jeong; Seo, Ji A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei Hyun